Kemoterapi
Ambudkar SV, Kimchi-Sarfaty C, Sauna ZE, Gottesman MM: P-glycoprotein: From Genomics to Mechanism. Oncogene, vol. 22, 7468-7485, 2003 (click here to open pubmed link)

Bush JA, Li G: Cancer Chemoresistance: The Relationship Between p53 and Multidrug Transporters. Int. J. Cancer, vol. 98, 536-545, 2002 (click here to open pubmed link)

Doyle LA, Ross DD: Multidrug Resistance Mediated by the Breast Cancer Resistance Protein BCRP (ABCG2). Oncogene, vol. 22, 7340-7358, 2003 (click here to open pubmed link)

Gottesman MM, Fojo T, Bates SE: Multidrug Resistance in Cancer: Role of ATP-dependent Transporters. Nat Rev Cancer, vol. 2, 48-58, 2002 (click here to open pubmed link)

Kellner U, Sehested M, Jensen PB, Gieseler F, Rudolph P: Culprit and Victim - DNA Topoisomerase II. Lancet Oncol., vol. 3, 323-330, 2002 (click here to open pubmed link)

Litman T, Druley TE, Stein WD, Bates SE: From MDR to MXR: New Understanding of Multidrug Resistance Systems, their Properties and Clinical Significance. Cell Mol Life Sci., vol. 58, 931-959, 2001 (click here to open pubmed link)

Relling MV, Dervieux T: Pharmacogenetics and Cancer Therapy. Nature Reviews, vol. 1, 99-108, 2001 (click here to open pubmed link)

Robert J: Multidrug Resistance in Oncology: Diagnostic and Therapeutic Approaches. Journal of Clinical Inv., vol. 29, 536-545, 1999 (click here to open pubmed link)